Uninsured and underinsured insulin syringe market — the estimated twenty-five to thirty million uninsured Americans including approximately two to three million requiring insulin therapy creating the value-focused commercial market relying on affordable vials and syringes as the only financially accessible insulin delivery option — represents an important and often overlooked...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt